The predictive value of CHA2DS2-VASc score on in-hospital death and adverse periprocedural events among patients with the acute coronary syndrome and atrial fibrillation who undergo percutaneous coronary intervention: a 10-year National Inpatient Sample (NIS) analysis.

[1]  P. Kirchhof,et al.  Effect of Concomitant Atrial Fibrillation on In-Hospital Outcomes of Non-ST-Elevation-Acute Coronary Syndrome-Related Hospitalizations in the United States. , 2019, The American journal of cardiology.

[2]  Deepak L. Bhatt,et al.  Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[3]  S. de Servi,et al.  Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low‐Dose Prasugrel or Clopidogrel , 2019, Journal of the American Heart Association.

[4]  J. Uhm,et al.  CHA2DS2-VASc score predicts exercise intolerance in young and middle-aged male patients with asymptomatic atrial fibrillation , 2018, Scientific Reports.

[5]  A. Tekkeşin,et al.  Association of the CHA2DS2VASc Score with Acute Stent Thrombosis in Patients with an ST Elevation Myocardial Infarction Who Underwent a Primary Percutaneous Coronary Intervention , 2018, Medical Principles and Practice.

[6]  G. Lip,et al.  Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc? , 2018, Circulation.

[7]  D. Cox,et al.  Influence of Atrial Fibrillation on Outcomes in Patients Who Underwent Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. , 2017, The American journal of cardiology.

[8]  P. Kolh,et al.  2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  E. Kontopantelis,et al.  Impact of Access Site Practice on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Following Thrombolysis for ST-Segment Elevation Myocardial Infarction in the United Kingdom: An Insight From the British Cardiovascular Intervention Society Dataset. , 2017, JACC. Cardiovascular interventions.

[10]  G. Aksan,et al.  The Value of CHA2DS2VASC Score in Predicting All-Cause Mortality in Patients with ST-Segment Elevation Myocardial Infarction Who Have Undergone Primary Percutaneous Coronary Intervention. , 2017, Acta Cardiologica Sinica.

[11]  G. Lip,et al.  Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks. , 2017, American journal of hypertension.

[12]  Yaohua Tian,et al.  CHA2DS2-VASc score as predictor of ischemic stroke in patients undergoing coronary artery bypass grafting and percutaneous coronary intervention , 2017, Scientific Reports.

[13]  G. Lip,et al.  Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. , 2016, The New England journal of medicine.

[14]  R. Ozturk,et al.  CHA2DS2-VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention , 2016, Angiology.

[15]  Laura Mauri,et al.  2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Journal of the American College of Cardiology.

[16]  H. Gurm,et al.  Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. , 2016, Journal of the American College of Cardiology.

[17]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.

[18]  Hua Shen,et al.  CHADS2 and CHA2DS2-VASc Scoring Systems for Predicting Atrial Fibrillation following Cardiac Valve Surgery , 2015, PloS one.

[19]  M. Jeong,et al.  The CHA2DS2VASc score can be used to stratify the prognosis of acute myocardial infarction patients irrespective of presence of atrial fibrillation. , 2015, Journal of cardiology.

[20]  K. Nair,et al.  Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both , 2014, Vascular health and risk management.

[21]  L. Chen,et al.  Temporal trends in the occurrence and outcomes of atrial fibrillation in patients with acute myocardial infarction (from the Atherosclerosis Risk in Communities Surveillance Study). , 2014, The American journal of cardiology.

[22]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[23]  P. Andersen,et al.  New‐Onset Atrial Fibrillation is Associated With Cardiovascular Events Leading to Death in a First Time Myocardial Infarction Population of 89 703 Patients With Long‐Term Follow‐Up: A Nationwide Study , 2014, Journal of the American Heart Association.

[24]  S. Anderson,et al.  Baseline bleeding risk and arterial access site practice in relation to procedural outcomes after percutaneous coronary intervention. , 2013, Journal of the American College of Cardiology.

[25]  G. Rennert,et al.  CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation. , 2014, The American journal of medicine.

[26]  Hugh Calkins,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2014, Journal of the American College of Cardiology.

[27]  Tze-Fan Chao M D And,et al.  Stroke Risk Predictor Scoring Systems in Atrial Fibrillation. , 2014, Journal of atrial fibrillation.

[28]  A. Alsheikh-Ali,et al.  Prognostic Significance of Prevalent and Incident Atrial Fibrillation Among Patients Hospitalized with Acute Coronary Syndrome , 2012, Angiology.

[29]  G. Ambrosio,et al.  Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis , 2012, Current Cardiology Reports.

[30]  Mårten Rosenqvist,et al.  Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. , 2012, European heart journal.

[31]  James Floyd,et al.  A systematic review of validated methods for identifying atrial fibrillation using administrative data , 2012, Pharmacoepidemiology and drug safety.

[32]  W. Abhayaratna,et al.  Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. , 2011, Heart rhythm.

[33]  X. Jouven,et al.  Mortality Associated With Atrial Fibrillation in Patients With Myocardial Infarction: A Systematic Review and Meta-Analysis , 2011, Circulation.

[34]  S. Yusuf,et al.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study , 2010, The Lancet.

[35]  J. Danesh,et al.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. , 2010, Lancet.

[36]  Gregory Y H Lip,et al.  Improving stroke risk stratification in atrial fibrillation. , 2010, The American journal of medicine.

[37]  P. Palatini,et al.  Atrial fibrillation during acute myocardial infarction: association with all‐cause mortality and sudden death after 7‐year of follow‐up , 2009, International journal of clinical practice.

[38]  D. Singer,et al.  Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study , 2005, Circulation.